Sichuan Academy of Medical Sciences &Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610072, China
Location status: Recruiting
Location contact
Mengchang Yang
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07195604
The study is being conducted to evaluate the safety and tolerability of HRS-2162 injection in a single dose in healthy subjects, as well as the characteristics of PK/PD
Interested in participating?
Request Info18 year–45 year
All sexes
Interventional
Phase 1
Chengdu, Sichuan, 610072, China
Location status: Recruiting
Mengchang Yang
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
HRS-2162
Placebo
Time frame: From ICF signing date to Day7
Time frame: 0 hour to 24 hour after administration
Time frame: 0 hour to 24 hour after administration
Time frame: 0 hour to 24 hour after administration
Time frame: 0 hour to 24 hour after administration
Time frame: 0 hour to 24 hour after administration
Time frame: 0 hour to 24 hour after administration
Time frame: 0 hour to 1 hour after administration
Contact information is provided by the study sponsor or research team.
Fujian Shengdi Pharmaceutical Co., Ltd.
Industry
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Single Dose of HRS-2162 Injection in Healthy Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06794450
Neuromuscular Blocking Agents, Recovery Time
Bandung, West Java, Indonesia
View Trial DetailsNCT05887375
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Columbia, Missouri, United States
View Trial DetailsNCT07044180
Delayed Emergence from Anesthesia, Neuromuscular Blocking Agents
Debrecen, Hungary
View Trial DetailsNCT07044193
Delayed Emergence from Anesthesia, Neuromuscular Blocking Agents
Debrecen, Hajdú-Bihar, Hungary
View Trial Details